LEO Pharma Submits Adolescent Label Expansion Application for Anzupgo® to EMA

LEO Pharma has submitted a label expansion application to EMA to expand Anzupgo® (delgocitinib) cream to adolescent patients ...
Pharmabiz

Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication

Aflibercept 8 mg recommended for marketing authorization in EU for third retinal indication: Berlin Monday, December 15, 2025, 13:00 Hrs [IST] The Committee for Medicinal Products ...
PharmiWeb

Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten

Everest Medicines announced on Dec. 11, 2025 that its wholly-owned subsidiary, Everest Medicines (China) Co., Ltd , has entered into two strategic agreements with privately held Hasten ...
Pharmabiz

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands

Biocon launches its glucagon-like peptide-1, liraglutide in Netherlands: Our Bureau, Bengaluru Monday, December 15, 2025, 13:30 Hrs [IST] Biocon has launch of its GLP-1 peptide, l ...